Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MODUS-THERAPEUTICS-HOLDIN-125090834/news/Modus-Therapeutics-Holding-AB-announces-first-clinical-trial-participant-dose-with-sevuparin-clinica-37192706/?utm_source=whatsapp&utm_medium=social&utm_campaign=share